|
A more recent version of this article appeared on March 17, 2006
Papers In Press, published online ahead of print January 17, 2006
J. Biol. Chem, 10.1074/jbc.M509782200
Submitted on September 6, 2005
Accepted on January 17, 2006
Direct cross-talk of interleukin-6 and insulin signal transduction via insulin receptor substrate-1 in skeletal muscle cells
Cora Weigert, Anita M. Hennige, Rainer Lehmann, Katrin Brodbeck, Frank Baumgartner, Myriam Schauble, Hans U. Haring, and Erwin D. Schleicher
Department of Internal Medicine, Division of Endocrinology, Metabolism, Clinical Chemistry and Pathobiochemie, University of Tuebingen, Tuebingen 72076
Corresponding Author: caweiger{at}med.uni-tuebingen.de
The exercise-induced interleukin (IL)-6 production and secretion within skeletal muscle fibers has raised the question of a putative tissue-specific function of IL-6 in the energy metabolism of the muscle during and after the exercise. In the present study we followed the hypothesis that IL-6 signaling may directly interact with insulin receptor substrate (IRS)-1 a keystone in the insulin signaling cascade. We show that IL-6 induces a rapid recruitment of IRS-1 to the IL-6 receptor complex in cultured skeletal muscle cells. Moreover, IL-6 induces a rapid and transient phosphorylation of Ser-318 of IRS-1 in muscle cells and in muscle tissue, but not in the liver of IL-6 treated mice, probably via the IL-6-induced co-recruitment of PKC-d. This Ser-318 phosphorylation improves insulin-stimulated Akt phosphorylation and glucose uptake in myotubes, since transfection with a IRS-1/Glu-318 mutant simulating a permanent phospho-Ser-318 modification increased Akt phosphorylation and glucose uptake. Noteworthy, two inhibitory mechanisms of IL-6 on insulin action, phosphorylation of the inhibitory Ser-307 residue of IRS-1 and induction of SOCS-3 expression, were only found in liver, but not in muscle of IL-6-treated mice. Thus, the data provide evidence for a possible molecular mechanism of the physiological metabolic effects of IL-6 in skeletal muscle, thereby exerting short-term beneficial effects on insulin action.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Hoene, R. Lehmann, A. M. Hennige, A. K. Pohl, H. U. Haring, E. D. Schleicher, and C. Weigert
Acute regulation of metabolic genes and insulin receptor substrates in the liver of mice by one single bout of treadmill exercise
J. Physiol.,
January 1, 2009;
587(1):
241 - 252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Weigert, M. Kron, H. Kalbacher, A. K. Pohl, H. Runge, H.-U. Haring, E. Schleicher, and R. Lehmann
Interplay and Effects of Temporal Changes in the Phosphorylation State of Serine-302, -307, and -318 of Insulin Receptor Substrate-1 on Insulin Action in Skeletal Muscle Cells
Mol. Endocrinol.,
December 1, 2008;
22(12):
2729 - 2740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K. Pedersen and M. A. Febbraio
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
Physiol Rev,
October 1, 2008;
88(4):
1379 - 1406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Peter, C. Weigert, H. Staiger, K. Rittig, A. Cegan, P. Lutz, F. Machicao, H.-U. Haring, and E. Schleicher
Induction of stearoyl-CoA desaturase protects human arterial endothelial cells against lipotoxicity
Am J Physiol Endocrinol Metab,
August 1, 2008;
295(2):
E339 - E349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. H. Mortensen, K. Andersen, C. Fischer, A. R. Nielsen, S. Nielsen, T. Akerstrom, M.-b. Aastrom, R. Borup, and B. K. Pedersen
Calprotectin is released from human skeletal muscle tissue during exercise
J. Physiol.,
July 15, 2008;
586(14):
3551 - 3562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Schmitz-Peiffer and T. J. Biden
Protein Kinase C Function in Muscle, Liver, and {beta}-Cells and Its Therapeutic Implications for Type 2 Diabetes
Diabetes,
July 1, 2008;
57(7):
1774 - 1783.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Waraich, C. Weigert, H. Kalbacher, A. M. Hennige, S. Z. Lutz, H.-U. Haring, E. D. Schleicher, W. Voelter, and R. Lehmann
Phosphorylation of Ser357 of Rat Insulin Receptor Substrate-1 Mediates Adverse Effects of Protein Kinase C-{delta} on Insulin Action in Skeletal Muscle Cells
J. Biol. Chem.,
April 25, 2008;
283(17):
11226 - 11233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K A. H Iwen, O. Senyaman, A. Schwartz, M. Drenckhan, B. Meier, D. Hadaschik, and J. Klein
Melanocortin crosstalk with adipose functions: ACTH directly induces insulin resistance, promotes a pro-inflammatory adipokine profile and stimulates UCP-1 in adipocytes
J. Endocrinol.,
March 1, 2008;
196(3):
465 - 472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wei, K. Chen, A. T. Whaley-Connell, C. S. Stump, J. A. Ibdah, and J. R. Sowers
Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species
Am J Physiol Regulatory Integrative Comp Physiol,
March 1, 2008;
294(3):
R673 - R680.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Glund, A. Deshmukh, Y. C. Long, T. Moller, H. A. Koistinen, K. Caidahl, J. R. Zierath, and A. Krook
Interleukin-6 Directly Increases Glucose Metabolism in Resting Human Skeletal Muscle
Diabetes,
June 1, 2007;
56(6):
1630 - 1637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Mooney
COUNTERPOINT: INTERLEUKIN-6 DOES NOT HAVE A BENEFICIAL ROLE IN INSULIN SENSITIVITY AND GLUCOSE HOMEOSTASIS
J Appl Physiol,
February 1, 2007;
102(2):
816 - 818.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. E. Spangenburg, S. E. Shoelson, C. Weigert, R. Lehmann, E. D. Schleicher, J.-O. Jansson, V. Wallenius, J.-P. Bastard, C. Lagathu, M. Caron, et al.
Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis
J Appl Physiol,
February 1, 2007;
102(2):
820 - 823.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K. Pedersen, M. A. Febbraio, and R. A. Mooney
Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis
J Appl Physiol,
February 1, 2007;
102(2):
814 - 816.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Al-Khalili, K. Bouzakri, S. Glund, F. Lonnqvist, H. A. Koistinen, and A. Krook
Signaling Specificity of Interleukin-6 Action on Glucose and Lipid Metabolism in Skeletal Muscle
Mol. Endocrinol.,
December 1, 2006;
20(12):
3364 - 3375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Carey, G. R. Steinberg, S. L. Macaulay, W. G. Thomas, A. G. Holmes, G. Ramm, O. Prelovsek, C. Hohnen-Behrens, M. J. Watt, D. E. James, et al.
Interleukin-6 Increases Insulin-Stimulated Glucose Disposal in Humans and Glucose Uptake and Fatty Acid Oxidation In Vitro via AMP-Activated Protein Kinase.
Diabetes,
October 1, 2006;
55(10):
2688 - 2697.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|